Marsh & McLennan (MRSH) CIO sells 713 shares under Rule 10b5-1 plan

Q: What insider transaction did Paul Beswick report for MRSH?

Paul Beswick reported a sale of 713 shares of Marsh & McLennan Common Stock on 29 July 2026 at $198 per share . The transaction was executed under a previously adopted Rule 10b5-1 trading plan and reflects a routine planned trade.

Q: How many MRSH shares did Paul Beswick sell and at what price?

Paul Beswick sold 713 MRSH shares at a price of $198 per share . This was reported as a sale of Common Stock in an open market or private transaction , with the price stated on a per-share basis in the disclosure.

Q: What is Paul Beswick’s role at Marsh & McLennan (MRSH)?

Paul Beswick is identified as Senior Vice President and Chief Information Officer of Marsh & McLennan Companies. His status as an officer makes his trades in MRSH Common Stock reportable on Form 4 as an insider transaction.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Paul Beswick, SVP and Chief Information Officer of Marsh & McLennan Companies, reported selling 713 shares of Common Stock on 29 July 2026 at $198 per share. The sale was executed under a previously adopted Rule 10b5-1 trading plan, leaving him with 16,376 shares of direct holdings.

Insider Trade Summary 10b5-1

Net Seller: 713 shares

Net Sell 1 txn

Insider Beswick Paul

Role SVP, Chief Information Officer

Sold 713 shs ($141K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	713	$198.00	$141K

Holdings After Transaction: Common Stock — 16,376 shares (Direct)

Footnotes (1)

F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Key Figures

Shares Sold: 713 shares Sale Price: $198 per share Shares Held After: 16,376 shares

3 metrics

Shares Sold 713 shares Common Stock sale reported on 29 July 2026

Sale Price $198 per share Price for the 713-share Common Stock sale

Shares Held After 16,376 shares Direct Common Stock holdings after the reported sale

Key Terms

Rule 10b5-1 trading plan, open market or private transaction, Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction financial

"Sale in open market or private transaction"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/31/2026 - 04:03 PM Accepted by SEC EDGAR 07/31/2026 - 04:03 PM

FAQ

What insider transaction did Paul Beswick report for MRSH?

Paul Beswick reported a sale of 713 shares of Marsh & McLennan Common Stock on 29 July 2026 at $198 per share. The transaction was executed under a previously adopted Rule 10b5-1 trading plan and reflects a routine planned trade.

How many MRSH shares did Paul Beswick sell and at what price?

Paul Beswick sold 713 MRSH shares at a price of $198 per share. This was reported as a sale of Common Stock in an open market or private transaction, with the price stated on a per-share basis in the disclosure.

What are Paul Beswick’s remaining MRSH holdings after this sale?

After the reported transaction, Paul Beswick directly holds 16,376 shares of Marsh & McLennan Common Stock. This figure represents his direct ownership position immediately following the 713-share sale disclosed in the Form 4 filing.

Was the MRSH insider sale by Paul Beswick under a Rule 10b5-1 plan?

Yes. The disclosure states the sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by Paul Beswick. The Form 4 also has the Rule 10b5-1 checkbox affirmed, indicating the transaction was executed under a pre-arranged trading plan.

What is Paul Beswick’s role at Marsh & McLennan (MRSH)?

Paul Beswick is identified as Senior Vice President and Chief Information Officer of Marsh & McLennan Companies. His status as an officer makes his trades in MRSH Common Stock reportable on Form 4 as an insider transaction.

Does this MRSH Form 4 disclose any derivative transactions?

No derivative securities transactions are reported in this Form 4. The filing lists only a single non-derivative transaction: the sale of 713 shares of Marsh & McLennan Common Stock, with no options or other derivatives shown in the derivative summary.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beswick Paul

(Last)

(First)

(Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/29/2026		S⁽¹⁾		713	D	$198	16,376	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

	/s/ Tessa Patti, Attorney-in-fact	07/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR